A brain organoid derived from human induced pluripotent stem cells that displays nuclei of cells (blue) and layers of cerebral cortex (red and green). (Image: Penn Medicine News)
Organoids to rebuild the brain
Penn neuroscientists are developing innovative ways to treat neurological diseases, including implanting neural tissue like a brain organoid to rebuild brain circuitry.
Volunteers at the Food Bank for Monterey County’s drive-through food distribution in June 2020.
Researchers find link between food insecurity and cardiovascular death risk
Increasing rates of food insecurity in counties across the United States are independently associated with an increase in cardiovascular death rates among adults between the ages of 20 and 64.
Scientists engineer bacteria-killing molecules from wasp venom
A team led by scientists in the Perelman School of Medicine has engineered powerful new antimicrobial molecules from toxic proteins found in wasp venom.
Uncovering the neurological connections to COVID-19
A variety of research efforts across Penn are working to uncover the neurological implications of COVID-19, including stroke, neuroinflammation, and loss of smell.
Hospitalized COVID-19 patients have low risk of stroke
While researchers found that 2.4% of patients hospitalized for COVID-19 had an ischemic stroke—the most common type of stroke, a new study suggests this is likely due to existing risk factors, rather than COVID-19.
